or
Looking to list your PhD opportunities? Log in here.
The Ludwig Institute for Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. Our Branch at the University of Oxford has a range of exciting opportunities for exceptional students to join us in a world-class research environment at the UK’s premier university for medical research. We can offer fully funded 4-year PhD scholarships available at both home and international fee rates, with a tax-free stipend of £21,000 pa, commencing October 2024.
To find out more about our exciting research and studentship opportunities, please view our individual projects.
No Live Listings |
As part of the Nuffield Department of Clinical Medicine (NDM), the Ludwig Institute Oxford Branch benefits from its place in a unique scientific environment. NDM is a cutting-edge research and teaching institution at the University of Oxford, working across several clinical disciplines. Its global reach and significant breadth in terms of capabilities and capacity make us unique among departments of medicine across the world.
The Nuffield Department of Medicine's vision is Universal Health. Its mission is to save lives and improve the quality of life by advancing the diagnosis, prevention and treatment of disease. This is delivered by forging global partnerships and accelerating the discovery of new medicines.
The Old Road Campus is at the heart of the University of Oxford’s world-leading biomedical research and the University’s partnership with local hospitals means that science and medical care are closely integrated.
The Old Road Campus is home to the Churchill Hospital including its £100m cancer hospital, The Wellcome Trust Centre for Human Genomics, the Richard Doll Building (housing epidemiological studies and clinical trials services), and the NDM Research Building, Target Discovery Institute, Kennedy Institute and Big Data Institute.
It also has close links and convenient access to Oxford’s science area, the Weatherall Institute for Molecular Medicine and the John Radcliffe Hospital.